UATP has partnered the payment technology company

When using Windows 10, you may find that the Windows desktop has frozen and you can no longer use the Start Menu, click on programs, drag files, or switch between windows. When this happens, it may be caused by the Windows Explorer, or Explorer.exe, process having issues and can typically be fixed by restarting it. [...]

When making a change to the Registry, it is recommended that you first create a export of the entries that you are about to modify. This allows you to save the information to a Registry file, or .reg file, so that if a problem occurs you can import the original settings back into the Registry. [...]

With the release of the Windows 10 May 2019 Update, Microsoft introduced a new security feature called Tamper Protection that protects security settings for Windows Defender antivirus from being disabled by malware or third-party programs. [...]

This tutorial will explain how to find the version number for Windows Defender in Windows 10. [...]

Windows Defender allows you to perform a Custom scan that lets you specify the specific folder or drive you would like to scan for malware. As you only need to scan that one folder, the scan time will be much quicker than scanning an entire machine. [...]

One of the features of the Windows 10 Start Menu is a built-in Bing search when a local search fails to find anything. Whether it be due to privacy reasons, bugs, or just personal dislike, this article will explain how to disable Bing search in the Start Menu. [...]

This tutorial will explain how to install or uninstall Google Chrome in Windows. [...]

The web is made up of terrific content from all over the world and sometimes the content you want to read is written in a different language. Thankfully, Google Chrome has built-in support for the Google Translate service, which will automatically translate the page into a language of your choice. [...]

Peter Epstein of Epstein Research discusses the macro picture for precious metals prices and one junior that he believes will benefit from higher prices.

Visit the aureport.com for more information and for a free newsletter

Agora Financial's Byron King and John-Mark Staude of Riverside Resources offer their viewpoints on markets during the COVID-19 pandemic in this conversation with Maurice Jackson of Proven and...

Visit the aureport.com for more information and for a free newsletter

The Critical Investor discusses recent developments at the company that is exploring the Goliath Gold Project in Ontario.

Visit the aureport.com for more information and for a free newsletter

Ron Struthers of Struthers' Resource Stock Report details the value proposition of Bam Bam Resources and its flagship prospect.

Visit the aureport.com for more information and for a free newsletter

Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States.; Credit: /AP

Updated at 4:59 p.m. ET

The Food and Drug Administration has given emergency use authorization to the antiviral drug remdesivir to treat hospitalized patients with the coronavirus, President Trump on Friday told reporters at the White House.

Gilead CEO Daniel O'Day said remdesivir maker Gilead Sciences is donating 1.5 million vials of the drug and will work with the federal government to distribute it to patients in need.

The news comes days after preliminary results from a study of the drug showed it can help patients recover faster. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, hailed the findings earlier this week as "quite good news."

The authorization means remdesivir can be distributed in the U.S. and given intravenously to treat COVID-19 patients — both adults and children — who are hospitalized with severe disease, the FDA says. The agency defines that category as "patients with low blood oxygen levels or needing oxygen therapy or more intensive breathing support such as a mechanical ventilator."

Discussing the findings about the drug's ability to help COVID-19 patients, O'Day cautioned earlier Friday that remdesivir is used to treat advanced cases, in which people are already hospitalized. The recent positive findings, he said, are a starting point in the fight against the respiratory disease.

"We want to continue to see how we can expand remdesivir to more patient populations," O'Day said on NBC's Today show. "Clearly with other medicines and vaccines to come, this is part, I think — the beginning of our ability to make an impact on this devastating virus."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Speaker of the House Nancy Pelosi wears a mask on Capitol Hill on April 30. Members in the House will not return over coronavirus fears but the Senate is scheduled to return on Monday.; Credit: Saul Loeb/AFP via Getty Images

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell, in a rare joint statement on Saturday, declined an offer from the White House to make rapid COVID-19 tests available for Congress.

"Congress is grateful for the Administration's generous offer to deploy rapid COVID-19 testing capabilities to Capitol Hill, but we respectfully decline the offer at this time," Pelosi and McConnell said. "Our country's testing capacities are continuing to scale up nationwide and Congress wants to keep directing resources to the front-line facilities where they can do the most good the most quickly."

McConnell, R-Ky., plans to bring the Senate back into session on Monday, while Pelosi, D-Calif., and House Majority Leader Steny Hoyer, D-Md., said this week the House would not bring representatives back over coronavirus fears.

On Friday, Health and Human Services Secretary Alex Azar said on Twitter that the Trump administration would send three Abbott "point of care testing machines and 1,000 tests for their use" to Capitol Hill.

President Trump on Saturday tweeted: " No reason to turn it down, except politics. We have plenty of testing. Maybe you need a new Doctor over there. Crazy Nancy will use it as an excuse not to show up to work!"

Pelosi and Hoyer said they made the decision based on advice from the Capitol's attending physician, Brian Monahan. "The House physician's view was that there was a risk to members that was one he would not recommend taking," Hoyer said Tuesday.

So far, Rand Paul of Kentucky is the only senator to have tested positive for the coronavirus. In the House, seven members have tested positive or presumed to be positive for the coronavirus.

On Friday, McConnell shared guidelines from Monahan urging lawmakers and staff to maintain six feet of distance, limit the number of people in offices and to wear masks when possible.

Monahan has told Republican leaders that his office does not have the capacity to proactively test all 100 senators and can only test those who are ill, Politico reported.

This content is from Southern California Public Radio. View the original story at SCPR.org.

President Trump speaks at the White House Friday. He is replacing an official who issued a report that found testing delays and equipment shortages at hospitals.; Credit: Jim Watson/AFP via Getty Images

President Trump is moving to replace the Department of Health and Human Services watchdog whose office found severe shortages of medical supplies in hospitals as COVID-19 cases surged.

In a Friday night announcement, the White House named Jason Weida as its nominee to take the permanent inspector general post currently occupied by Christi Grimm, who's been in that role in an acting capacity since January.

A longtime staffer with Health and Human Services, Grimm was leading the inspector general's office in April when it issued a report chronicling testing delays — up to seven days in some cases — as well as severe shortages of supplies in hospitals amid the COVID-19 pandemic.

"Hospitals reported that they were unable to keep up with COVID-19 testing demands because they lacked complete kits and/or the individual components and supplies needed to complete tests," the survey of 323 hospitals found. "When patient stays were extended while awaiting test results, this strained bed availability, personal protective equipment (PPE) supplies, and staffing."

The report also recalled how one hospital had even resorted to making its own disinfectant.

Trump reacted to the report by calling its findings "wrong," asking to know the name of the inspector general and suggesting the report was politically motivated. He later took to Twitter to castigate Grimm and the report even further.

"Why didn't the I.G., who spent 8 years with the Obama Administration (Did she Report on the failed H1N1 Swine Flu debacle where 17,000 people died?), want to talk to the Admirals, Generals, V.P. & others in charge, before doing her report. Another Fake Dossier!" Trump tweeted in early April.

Grimm is a career official, not a political appointee, and began serving in the Office of the Inspector General in 1999.

The nomination of Weida — currently an assistant U.S. attorney — marks the latest replacement of a high-level watchdog by the president. A month ago, he fired the inspector general who raised concerns that eventually led to his impeachment. Days later, he removed the inspector general charged with overseeing the government's coronavirus response bill.

Sen. Patty Murray, ranking Democrat on the Health, Education, Labor and Pensions Committee, said that Trump's nominee "must not get through the Senate without ironclad commitments" to continue the agency's current investigations without political interference.

"We all know the President hasn't told people the truth about this virus or his Administration's response, and late last night, he moved to silence an independent government official who did," Murray said in a statement released on Saturday. "Anyone who demands less will be complicit in the President's clear pattern of retaliation against those who tell the truth."

Health and Human Services did not comment to NPR on Grimm's future role, but said in statement that the agency had been preparing "to assist a new Inspector General appointee over a year ago, when the previous presidentially-appointed and senate-confirmed Inspector General first announced his intention to retire from government service. We will continue to work conscientiously to support a smooth leadership transition."

This content is from Southern California Public Radio. View the original story at SCPR.org.

President Trump walks to the White House on Sunday, after returning from Camp David in Maryland.; Credit: Andrew Caballero-Reynolds/AFP via Getty Images

As President Trump attempts to project an image of America rising out of quarantine and beginning to reopen, he's set to travel to an Arizona factory that's expanded into production of N95 face masks to respond to the coronavirus pandemic.

And while the trip is in part meant to tell a positive story about the Trump administration's response, it also highlights the challenges of the current moment.

Arizona remains under a modified stay-at-home order until May 15, though Republican Gov. Doug Ducey allowed some retail establishments to begin to open voluntarily Monday. The state hasn't yet notched the two consecutive weeks of reduced COVID-19 cases called for as a first step in the White House guidelines for reopening. In fact, the number of confirmed cases in the state is on the rise.

And Trump's trip itself will be anything but normal. Those traveling with the president or coming in close proximity to him in Arizona are being tested for the coronavirus. Social distancing measures are expected.

"The President takes the health and safety of everyone traveling in support of himself and all White House operations very seriously," White House spokesman Judd Deere said in a statement provided to NPR. "When preparing for and carrying out any travel, the White House's operational teams work together to ensure plans to incorporate current CDC guidance and best practices for limiting COVID-19 exposure are followed to the greatest extent possible."

Asked last week if he would wear a mask on the trip, Trump was noncommittal.

"I'm going to have to look at the climate. I'd have no problem wearing a mask. I don't know," Trump said at the White House. "I'm supposed to make a speech. I just don't know: Should I speak in a mask? You're going to have to tell me if that's politically correct. I don't know. If it is, I'll speak in a mask."

Vice President Mike Pence faced criticism for not wearing a mask while visiting the Mayo Clinic in Minnesota last week, in apparent violation of the center's policy. Sitting next to Trump at a televised town hall Sunday night, Pence said he "should have worn a mask at the Mayo Clinic."

Pence has left Washington, D.C., a few times recently — a series of trips the White House used in part as test runs for Trump to get back on the road.

Different than the big rallies

Tuesday's travel is a far cry from Trump's last trip to Arizona, for a campaign rally on Feb. 19. He didn't mention the coronavirus in his speech that night, and when asked about it in an interview with a local TV reporter, he downplayed the risk.

"I think it's going to work out fine," Trump told Fox 10 Phoenix. "I think when we get into April, in the warmer weather, that has a very negative effect on that and that type of a virus. So let's see what happens, but I think it's going to work out fine."

As of Monday morning, more than 350 deaths had been attributed to COVID-19 in Arizona, according to researchers at Johns Hopkins University, with about 68,000 deaths nationwide.

Trump still yearns for those big rallies of the not-so-distant past, musing about the day when he can pack arenas again and not have to have people spaced 6 feet apart. But for now, he's relishing the idea of escaping the confines of the White House. Aside from a trip to the presidential retreat at Camp David last weekend, this will be Trump's first trip away from the White House since March 28, when he sent off the Navy hospital ship USNS Comfort in Norfolk, Va. While it's been a little more than a month, Trump has described himself as stuck at the White House "for many months."

In Phoenix, Trump will tour a Honeywell aerospace manufacturing facility that freed up space to start making N95 respirator masks. According to a company spokesman, the first masks rolled off the line on April 30, ahead of schedule. Once up to full capacity, it will make 10 million of the masks per month. The company said it would be adding 500 employees to make the masks. Another Honeywell factory in Rhode Island also started making masks last month. Most of them are headed to the federal government, which is distributing the protective equipment. Mask shortages have been a major concern for health care workers treating patients with the highly contagious coronavirus.

Battleground state

Although there isn't officially a political component to the trip, Arizona is a state Trump won in 2016, but that Democrats expect to be competitive in 2020.

Trump's visit clearly underscores how he isn't taking anything for granted in the state in 2020. His goal is to remind voters how the Arizona economy was booming before the pandemic.

"Arizona is a state where President Trump's campaign will be aggressive, where we have had a presence since 2015," said Erin Perrine, principal deputy communications director for the reelection campaign. "We will reach voters where ever they are — sharing the message that only President Trump can bring back the booming Trump economy and highlighting his strong leadership during the coronavirus."

For several election cycles, Democrats have been eyeing Arizona as a state they might put in the presidential win column. Analysts say Democrats challenge will will be to win in the suburbs and get a solid turnout from Hispanics, even as the pandemic's effect on campaigning and on the actual process of voting is yet to be known. No Democratic nominee had carried the state since Bill Clinton in 1996. In 2016, there was talk of a late play for the state by Hillary Clinton's campaign, but that was seen more as overconfidence than her actually have a real shot at winning there. Then, when the votes were counted, Trump won the presidency, including a victory in Arizona, but his margin in the state was only 3.5%.

Four years earlier, GOP nominee Mitt Romney carried the state over President Obama by more than 9 percentage points. Democrats took Trump winning so narrowly in the state as a sign that maybe the future was closer than people realized. Longtime GOP strategist Chuck Coughlin says Democrats kept the story line going two years later by winning four statewide offices, including an open U.S. Senate seat and secretary of state. Now strategist Coughlin says, "There is a trend line going on, Republicans have had to acknowledge that, and the swing voters have become more important — independents and Republican suburban women." He says those are the keys to a Democratic victory in the state.

An average of recent polls shows former Vice President Joe Biden, the presumptive Democratic presidential nominee, leading in head-to-head matchups. Although horse race polling this far out, and especially in the middle of an unprecedented crisis, isn't necessarily predictive, it's one of a few causes for alarm for Republicans.

In 2018, Democrat Kyrsten Sinema won an open U.S. Senate seat in Arizona. Another Senate seat is up in 2020, and the latest campaign finance reports show Democratic challenger Mark Kelly with nearly twice as much cash on hand as incumbent Republican Sen. Martha McSally. Kelly has also led in recent polls.

McSally portrays herself as a strong ally of Trump's, even echoing his style of negative campaigning. Here's how she began her remarks when Trump called her up to speak at that big rally in February, "I just want to say I have a message for the liberal hack media in the back," she told the noisy crowd, "Arizona is going to vote in November to keep America great and send President Trump back to the White House.

In April McSally tweeted that she was able to secure ventilators for her state after talking to Trump.

"Huge news for Arizona!" McSally tweeted. "I spoke with @realDonaldTrump on Wednesday afternoon to request additional ventilators from the Strategic National Stockpile. Today, POTUS delivers with 100 ventilators headed to AZ. Thank you to President Trump and @VP for hearing our call."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and CDC Director Robert Redfield will appear before a Senate committee on May 12.; Credit: Patrick Semansky/AP

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, will join Centers for Disease Control and Prevention Director Robert Redfield and other administration representatives in testifying before a Senate committee on May 12.

The announcement comes as members of President Trump's coronavirus task force are being asked to limit their appearances on Capitol Hill despite ongoing calls from lawmakers for more oversight into the administration's coronavirus response. Last week, the Trump administration blocked Fauci from appearing before a House committee on the subject of spending on coronavirus testing.

President Trump told reporters Tuesday that he doesn't want the officials appearing before House Democrats.

"The House is a setup," Trump said. "The House is a bunch of Trump haters."

White House officials gave a less adversarial explanation when justifying the decision to limit task force testimony in a memo to top congressional aides.

"For primary response departments, including HHS, DHS, and State, in order to preserve department-wide resources, no more than one COVID-related hearing should be agreed to with the department's primary House and Senate authorizing committee and appropriations subcommittee in the month of May, for a total of no more than four COVID-related hearings department-wide," the memo stated.

Congressional Democrats are demanding greater oversight over the roughly $3 trillion that has already been approved for the coronavirus response. House Speaker Nancy Pelosi, D-Calif., has launched a new select committee to conduct the oversight, but Republicans have so far refused to name members to the panel despite the plan to make the panel bipartisan.

The Senate hearing was announced shortly after the administration sent the memo to Capitol Hill banning committee appearances from task force members during May unless approved by the White House chief of staff.

Deputy White House Press Secretary Judd Deere said the decision to block Fauci from the House committee appearance was intended to allow him to focus on his primary task of overseeing the coronavirus response.

"While the Trump Administration continues its whole-of-government response to COVID-19, including safely opening up America again and expediting vaccine development, it is counter-productive to have the very individuals involved in those efforts appearing at Congressional hearings," Deere said. "We are committed to working with Congress to offer testimony at the appropriate time."

Fauci, Redfield, HHS Assistant Secretary Brett Giroir and FDA Commissioner Stephen Hahn are scheduled to discuss "safely getting back to work and back to school" when they appear before the Health, Education, Labor and Pensions — or HELP — Committee next Tuesday.

Senate Democrats, including Patty Murray, D-Wash., the top Democrat on the HELP committee, have called for the administration to provide greater transparency and a nationwide plan for testing. So far their demands have not received a response.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Senate Majority Leader Mitch McConnell has made filling judicial vacancies his top priority ahead of the 2020 elections.; Credit: J. Scott Applewhite/AP

As new allegations emerge about his motives for retirement, Judge Thomas Griffith says that he faced no political pressure in his decision to leave the bench.

"My decision was driven entirely by personal concerns and involved no discussions with the White House or the Senate," he said in a statement provided to NPR.

Griffith said that his wife was diagnosed 11 years ago with a "debilitating chronic illness" and that her health was "the sole reason for my retirement." He said he made the decision to retire in June 2019 and privately informed his family and law clerks at the time. His retirement was announced publicly in March.

Griffith, 65, is a circuit court judge on the U.S. Court of Appeals for the District of Columbia. Appointed by President George W. Bush, he has served since 2005.

On Monday, The New York Times reported that Demand Justice, a liberal judicial advocacy group, filed a complaint that raises questions about whether Griffith's decision was tied to efforts by Senate Majority Leader Mitch McConnell to encourage older, conservative judges to retire in order to fill their vacancies with younger, conservative judges ahead of the 2020 election, when control of the White House and the Senate will be in play.

Griffith's retirement has paved the way for Justin Walker's nomination to fill the vacancy. Walker, 37, is a longtime McConnell ally who is currently serving as a U.S. district judge of the Western District of Kentucky, McConnell's home state.

The Demand Justice complaint was directed to the U.S. Court of Appeals, where the court's chief judge, Sri Srinivasan, has asked Chief Justice John Roberts to assign another circuit to look into the complaint about whether any ethical improprieties occurred. Griffith's statement refutes the core allegation — that his decision was fueled by political considerations or the result of a pressure campaign.

These allegations are likely to come up at Walker's confirmation hearing on Wednesday before the Senate Judiciary Committee.

Democrats broadly oppose Walker's nomination. He was rated "not qualified" by the American Bar Association. However, unless support for him is diminished among Republicans — unlikely with McConnell's backing — he is likely to be confirmed.

This content is from Southern California Public Radio. View the original story at SCPR.org.

President Trump speaks in the Oval Office Wednesday.; Credit: Evan Vucci/AP

In a whistleblower complaint filed this week, top federal scientist Rick Bright alleges he was removed from his post for failing to go along with the president's push to promote a drug as a cure for COVID-19.

On Wednesday, Trump dismissed the complaint, telling reporters Bright "seems like a disgruntled employee who's trying to help the Democrats win an election."

"I never met him, I know nothing about him," Trump said, adding that he didn't think "disgruntled people" should work for his administration.

Trump also observed that Bright is being represented by a legal team that represented "other people" – seemingly an allusion to lawyer Debra Katz's representation of Christine Blasey Ford, who testified against Supreme Court Justice Brett Kavanaugh during his confirmation.

Bright's legal team declined to comment.

Bright says he was ousted from his position as director of the Biomedical Advanced Research and Development Authority because he wanted to spend money on safe and vetted treatments for COVID-19 — not hydroxychloroquine. The president has called that common anti-malaria drug a possible "game-changer," but there is no proof that it works for COVID patients, and it has side effects. The Food and Drug Administration ultimately warned against using the drug to treat COVID-19 without "strict medical supervision."

This content is from Southern California Public Radio. View the original story at SCPR.org.

"For Sale By Owner" and "Closed Due to Virus" signs are displayed in the window of Images On Mack in Grosse Pointe Woods, Mich. Congress is considering ways to help those struggling during the economic downturn and stabilize businesses hoping to reopen.; Credit: Paul Sancya/AP

Updated at 3:20 p.m. ET

Democrats and some Republicans are considering ways for the federal government to get money into people's pockets while the coronavirus is keeping much of the economy on ice.

Proposals for the next round of aid are being floated, and Democrats in the House are prepping another relief package as jobless claims continue to rise in the country. The Labor Department announced Friday that 20.5 million jobs were lost in April, pushing the overall unemployment rate to 14.7 %.

House Speaker Nancy Pelosi, D-Calif., hopes to release another bill, which is being crafted without the input of Republicans or the White House as early as next week.

"This is a reflection of the needs of the American people," Pelosi said Thursday. "We have to start someplace and, rather than starting in a way that does not meet the needs of the American people, want to set a standard."

The latest proposal from Sens. Kamala Harris, D-Calif., Bernie Sanders, I-Vt., and Ed Markey D-Mass., is a plan for the federal government to provide $2,000 a month for every individual earning less than $120,000, including children and other dependents. The draft legislation would extend the payments until three months after the public health emergency is lifted.

The proposal is a vast expansion on the recovery rebate program that sent a one-time payment of $1200 to every person earning less than $75,000 and an additional $500 for every child.

The trio of Democratic senators wants to make the payments, which would be available to every U.S. resident, retroactive to March. They didn't provide a cost estimate for the ambitious proposal, and it's unclear whether Senate leaders have an appetite for payments like these.

Official scorekeepers at the Congressional Budget Office estimate that the existing one-time $1200 payment program in the CARES Act package enacted in March could cost around $300 billion. Republican leaders have signaled concerns with the growing cost of the relief bills that have already passed.

Senate Majority Leader Mitch McConnell, R-Ky., has called for a pause on any new aid.

"Let's see what we are doing that is succeeding, what is not succeeding, what needs less, what needs more," McConnell told reporters in April. "Let's weigh this very carefully because the future of our country in terms of the amount of debt that we are adding up is a matter of genuine concern."

Not all Republicans agree. Sen. Josh Hawley, R-Mo., has introduced a comprehensive response plan that includes a proposal to cover 80 percent of payroll for companies that rehire workers and a bonus for the companies that take advantage of the program.

"The federal government should cover 80 percent of wages for workers at any U.S. business, up to the national median wage, until this emergency is over," Hawley wrote in an editorial in The Washington Post. "The goal must be to get unemployment down — now — to secure American workers and their families, and to help businesses get ready to restart as soon as possible."

Hawley's proposal would cap payments at the national median income level. The median income can be calculated in several different ways. Hawley told St. Louis Public radio the payments could be as high as $50,000. Other calculation set the figure at roughly $33,000, a figure many Democrats say is not sufficient in higher-cost areas like cities.

House Progressive Caucus co-chair Rep. Pramila Jayapal, D-Wash., has a separate version that would guarantee a worker's full salary up to $100,000 for three months. Jayapal's plan would automatically renew the payments on a monthly basis until consumer demand returns to pre-crisis levels.

The proposal has nearly two dozen co-sponsors but has not received an endorsement from party leadership.

Pelosi has not ruled out the possibility of including some minimum income payments in an upcoming coronavirus aid bill.

"We may have to think in terms of some different ways to put money in people's pockets," Pelosi said in an interview with MSNBC. "Let's see what works, what is operational and what needs other attention."

This content is from Southern California Public Radio. View the original story at SCPR.org.

The Trump administration asked the Supreme Court to block Congress from seeking the materials, saying, "The government will suffer irreparable harm absent a stay."; Credit: Andrew Harnik/AP

The Supreme Court has temporarily put on hold the release of redacted grand jury material from the Russia investigation to a House panel.

The Trump administration is trying to block the release.

Last October, a district court judge ruled the Justice Department had to turn over the materials, which were blacked out, from former special counsel Robert Mueller's report into Russian interference in the 2016 election.

An appeals court upheld the decision, but the Trump administration, hoping to keep the evidence secret, appealed to the Supreme Court.

Chief Justice John Roberts' order temporarily stops the process. Lawyers for the House Judiciary Committee have until May 18 to file their response to the Justice Department's attempts to keep the materials from the House panel.

The Justice Department had until Monday to turn over the material following the appeals court order. But on Thursday, the Trump administration asked the Supreme Court to block Congress from seeking it, saying, "The government will suffer irreparable harm absent a stay."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Rick Bright filed a complaint this week with the Office of Special Counsel, a government agency responsible for whistleblower complaints.; Credit: /Public Health Emergency via AP

Attorneys for Rick Bright, the government scientist who said he had been reassigned and subsequently filed a whistleblower complaint, say a government watchdog agrees that he should be reinstated to his post.

Bright was serving as director of the Biomedical Advanced Research and Development Authority, which is working on a vaccine to combat the coronavirus.

He said he was ousted from the position last month because he wanted to spend money on safe and vetted treatments for COVID-19 — not on ones without "scientific merit," such as hydroxychloroquine, the anti-malarial drug that President Trump and others had been touting.

Trump on Wednesday called Bright "a disgruntled employee who's trying to help the Democrats win an election."

Bright's attorneys say that the Office of Special Counsel, which hears whistleblower cases, determined there were "reasonable grounds" to believe that his removal was retaliatory and therefore prohibited.

Bright's attorneys say OSC plans to contact the Department of Health and Human Services to request that it put Bright's removal on hold for 45 days so the office can complete its investigation into the allegations.

The OSC said it "cannot comment on or confirm the status of open investigations."

In a statement to NPR, Caitlin Oakley, a spokesperson for HHS, said: "This is a personnel matter that is currently under review. However, HHS strongly disagrees with the allegations and characterizations in the complaint from Dr. Bright."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Symend, a Canada-based digital engagement platform, has raised USD 52 million to identify customers having trouble with their bills to keep them from defaulting.

A 2018 exhibit at the Billy Ireland Cartoon Library & Museum at Ohio State University celebrated the artistic legacy of MAD magazine.; Credit: Andrew Welsh-Huggins/AP

The funny, freckled face of Alfred E. Neuman is more or less retiring.

One of the last widely circulated print satirical magazines in America will leave newsstands after this year, according to sources at DC Comics, which publishes MAD magazine.

While the Harvard Lampoon remains in business, The Onion hasn't been in print since 2013. The once-influential Spy was a casualty of the 1990s.

At MAD's peak in the early 1970s, more than 2 million people subscribed to it, both for its pungent political humor and deeply adolescent jokes.

In 2017, that number had reportedly dropped to 140,000.

MAD isn't completely shutting down, but it will be radically downsized and changed.

Readers will only be able to find the 67-year-old humor magazine at comic book stores and through subscriptions.

After issue No. 10 this fall, there will no longer be new content, except for end-of-year specials which will be all new. Starting with issue No. 11, the magazine will feature classic, best-of and nostalgic content, repackaged with new covers.

This content is from Southern California Public Radio. View the original story at SCPR.org.

The entrance to the planned 17,000 sq.-foot Korean American National Museum to be built in Koreatown. ; Credit: Morphosis Architects

The Korean American National Museum is on pace to break ground next year on the corner of Vermont and Sixth.

New designs unveiled this week show an airy, modern-looking building that will include elements of Korean design and house photographs and other artifacts.  

Read more on LAist.com.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Henry E. Huntington in 1907.; Credit: Theo C. Marceau, New York City. The Huntington Library, Art Museum, and Botanical Gardens

One of the most prized treasures of LA County is 100 years old this year.

The Huntington Library is beloved for its lush botanical gardens and fine art.

As KPCC's Brianna Flores reports, you can trace its origins to a pivotal moment in Southern California history.

This content is from Southern California Public Radio. View the original story at SCPR.org.

David Biello; Credit: /Elizabeth Zeeuw / TED

About The Episode

There's so much we've yet to explore—from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.

About David Biello

As TED's Science Curator, David Biello finds scientists with spectacular stories of discovery and helps them bring those stories to life on the TED stage.

A science journalist by trade, he is also a contributing editor at Scientific American, where he's been since 2005. He has also written for Yale E360, Aeon, Foreign Policy, The New York Times and New Republic. David has been a guest on numerous television and radio shows, and he hosts the ongoing duPont-Columbia award-wining documentary "Beyond the Light Switch" as well as "The Ethanol Effect" for PBS.

Biello is the author of The Unnatural World: The Race to Remake Civilization in Earth's Newest Age. He received a BA in English from Wesleyan University and a MS in Journalism from Columbia University.

Featured Speakers

Juna Kollmeier: The Most Detailed Map Of Galaxies, Black Holes And Stars Ever Made

Humans have charted stars for thousands of years, but Juna Kollmeier wants to make the most complete map of the universe ever concieved — by 3D imaging millions of stars, black holes, and galaxies.

Enrico Ramirez-Ruiz: Your Body Was Forged In The Spectacular Death Of Stars

Astrophysicist and self-proclaimed "stellar mortician" Enrico Ramirez-Ruiz takes us through the spectacular life and death of supernovas that make all living things the stuff of stars.

Karen Lloyd: The Mysterious Microbes Living Deep Inside The Earth — And How They Could Help Humanity

Deep beneath our feet and beyond the ocean floor, there is a world teeming with microbes that get their energy not from the sun but from rocks. Karen Lloyd leads us into the alien world below.

Victor Vescovo: What's At The Bottom Of The Ocean — And How We're Getting There

Victor Vescovo has a submarine that takes him further down into the ocean than the height of Mt. Everest. He's been to the deepest parts of our five oceans, revealing lifeforms that defy imagination.

Kay M. Tye: What Investigating Neural Pathways Can Reveal About Mental Health

Behavior, emotion ... it's all in our heads. Kay M. Tye has found neural pathways that create specific emotional or behavioral states — and she's made a switch to turn them on and off.

This content is from Southern California Public Radio. View the original story at SCPR.org.